During the past decade, City Clinical Hospital 24 conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 4 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "City Clinical Hospital 24" #1 sponsor was "Celgene" with 5 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Alfasigma S.p.A." with 1 trials sponsored and "Biocad" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

According to Clinical.Site data, the most researched conditions in "City Clinical Hospital 24" are "Multiple Sclerosis" (5 trials), "Crohn Disease" (4 trials), "Colitis, Ulcerative" (2 trials), "Crohn's Disease" (2 trials) and "Anemia" (1 trials). Many other conditions were trialed in "City Clinical Hospital 24" in a lesser frequency.

Most popular intervention types in "City Clinical Hospital 24" are "Drug" (18 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (5 trials), "Placebo" (5 trials), "Ozanimod" (4 trials), "Antihistamine" (2 trials) and "Methylprednisolone" (2 trials). Other intervention names were less common.

The vast majority of trials in "City Clinical Hospital 24" are 18 trials for "All" genders.

Currently, there are NaN active trials in "City Clinical Hospital 24". 1 are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in City Clinical Hospital 24, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in City Clinical Hospital 24, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".